LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Automated Microscope Classifies IIF Patterns in Autoimmune Dermatoses

By LabMedica International staff writers
Posted on 02 May 2023
Image: Exemplary images of IIF on esophagus and salt-split skin (Photo courtesy of EUROIMMUN)
Image: Exemplary images of IIF on esophagus and salt-split skin (Photo courtesy of EUROIMMUN)

Autoimmune bullous dermatoses (AIBD) are a diverse group of autoantibody-driven conditions characterized by blistering and erosion of the skin and mucous membranes, including pemphigus diseases, pemphigoid diseases, and dermatitis herpetiformis. Differentiating between disease sub-types is essential for making treatment decisions. Indirect immunofluorescence (IIF) microscopy using tissue sections of the esophagus and salt-split skin is one of the most sensitive screening methods for initially differentiating AIBD. IIF on esophagus identifies autoantibodies against epithelial and endomysial antigens, while IIF on salt-split skin differentiates autoantibodies against the basement membrane zone. However, interpreting the complex IIF patterns can be challenging and is not well standardized.

In a joint study, scientists at EUROIMMUN (Lübeck, Germany) and the University of Lübeck (Lübeck, Germany) have developed and assessed a computer-aided system for classifying IIF patterns on esophagus and salt-split skin samples. The scientists created the training datasets by incubating biochip slides containing millimeter-sized tissue sections with various dilutions of patient serum samples and controls. Subsequently, the team used the EUROPattern Microscope 1.5 to acquire images. The results of the computer-aided evaluation were compared with findings from manual evaluations by experienced IIF technicians.

Automated IIF evaluation on esophagus and salt-split skin presents a challenge, as the small structures necessary for classification are only present in certain areas of the tissue substrates. Standard deep networks are not suitable for processing these images due to computer memory limitations and the number of available training images. Consequently, the researchers employed segmentation to focus the classification networks on the essential regions. The developed algorithms demonstrated high accuracy for pattern classification on esophagus and salt-split skin, with over 95% agreement with visual reading results. The positive predictive agreement was above 97% for all positive IF patterns on both tissue substrates, while the negative predictive agreement was at least 95% for all patterns.

The researchers concluded that deep networks can be adapted for evaluating complex tissue substrates by incorporating the segmentation of relevant regions into the prediction process. These classifiers offer an excellent enhancement to AIBD screening methods and can reduce the workload for professionals when interpreting tissue sections in IIF testing.

Related Links:
EUROIMMUN 
University of Lübeck 

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
Laboratory Software
ArtelWare

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more